How is the InflaRx N.V. today?

The InflaRx N.V. today is trading in the down by -2.50% at 0.78.

How has InflaRx N.V. performed historically?

The InflaRx N.V. is currently trading down -2.50% on an intraday basis in the past week the index fell -6.02%. The index has been down -32.17% in the past quarter and fell -48.68% in the past year. You can view this in the overview section.

What is InflaRx N.V. Annual Revenue?

InflaRx N.V. Annual Revenue rose 162.78%, in the last year to $0.17 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is InflaRx N.V. Annual Net Profit?

InflaRx N.V. Annual Net Profit fell 7.96% in the last year to $46.06 M. Its sector's average net profit growth for the last fiscal year was -13.89%.

What is InflaRx N.V. Price to Earning Ratio?

InflaRx N.V. Price to Earning Ratio is -1.02, which is negative.

What is InflaRx N.V. Stock Price?

InflaRx N.V. Stock Price fell 48.68% and underperformed its sector by 73.49% in the past year.

What is InflaRx N.V. Quarterly Net profit?

InflaRx N.V. Quarterly Net profit rose 13.91% YoY to $8.31 M. Its sector's average net profit growth YoY for the quarter was -238.55%.

What is InflaRx N.V. Debt to Equity Ratio?

InflaRx N.V. Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is InflaRx N.V. Return on Equity(ROE)?

InflaRx N.V. Return on Equity(ROE) for the last financial year was -56.18%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is InflaRx N.V. Mutual Fund Holding?

InflaRx N.V. Mutual Fund Holding decreased by 0.03% in the last quarter to 0.15.

What is InflaRx N.V. Interest Coverage Ratio?

InflaRx N.V. Interest Coverage Ratio is -2228.93, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is InflaRx N.V. Institutional Holding?

InflaRx N.V. Institutional Holding increased by 6.87% in the last quarter to 26.09.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
INFLARX N.V.

InflaRx N.V. XNAS: IFRX

InflaRx N.V. Live Share Price Today, Share Analysis and Chart

Name: InflaRx N.V.: Is Infosys Ltd. worth buying?
Item: InflaRx N.V.
Rating: 0.78166675
Author: Trendlyne DVM scores

about

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its recepto...

0.78 -0.02 (-2.50%)

72.34% Fall from 52W High

819.5K

XNAS Volume

XNAS 13 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

15.2 / 100

Technically Bearish

16.1 / 100

1Yr Price target upside is 373%

6 analysts

InflaRx N.V. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

InflaRx N.V. Live Share Price Today, Share Analysis and Chart

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its recepto...

72.34% Fall from 52W High

InflaRx N.V. Live Price Chart

InflaRx N.V. FAQ

How is InflaRx N.V. today?

InflaRx N.V. today is trading in the red, and is down by -2.50% at 0.78.

How has InflaRx N.V. performed historically?

InflaRx N.V. is currently trading down -2.50% on an intraday basis. In the past week the stock fell -6.02%. stock has been down -32.17% in the past quarter and fell -48.68% in the past year. You can view this in the overview section.